Avalo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Avalo Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 89% to $1,924,000. The net income raised on -$31,544,000 and profit margin reached -1640%. Total operating expenses were $640,000.
Profit Margin
| 2014 | 0 | -16.05M | |
|---|---|---|---|
| 2015 | 0 | -10.49M | |
| 2016 | 1.15M | -16.47M | -1428.53% |
| 2017 | 27.81M | 11.86M | 42.68% |
| 2018 | 18.32M | -40.05M | -218.55% |
| 2019 | 6.75M | -16.27M | -241.05% |
| 2020 | 6.69M | -64.38M | -961.1% |
| 2021 | 5.39M | -84.34M | -1562.6% |
| 2022 | 18.05M | -41.65M | -230.78% |
| 2023 | 1.92M | -31.54M | -1639.5% |
AVTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.92M | 18.05M | 5.39M | 6.69M | 6.75M | 18.32M | 27.81M | 1.15M | 0 | 0 |
Cost of revenue | 1.28M | 3.43M | 1.49M | 300K | 11.62M | 7.47M | 635.64K | 0 | 23.50K | 9.5M |
Gross profit | 640K | 14.61M | 3.90M | 6.39M | -4.87M | 10.84M | 27.17M | 1.15M | -23.50K | -9.5M |
Operating exp. | ||||||||||
Research and development | 13.78M | 31.30M | 59.83M | 32.19M | 11.76M | 5.78M | 4.37M | 10.15M | 6.58M | 12.24M |
Selling and marketing | 33K | 76K | 2.82M | 2.34M | 1.48M | 8.52M | 973.34K | 0 | 0 | 0 |
Total operating expenses | 640K | 52.05M | 86.04M | 53.69M | 24.71M | 29.51M | 13.28M | 17.23M | 11.01M | 17.11M |
Operating income | -23.44M | -37.44M | -82.13M | -26.95M | -17.39M | -39.31M | 13.88M | -16.08M | -11.01M | -17.11M |
Other income (expenses), net | -8.08M | -4.19M | -2.41M | 5.66M | 1.40M | -20.60M | -53.64K | 73K | 519.84K | 1.05M |
Income before tax | -31.53M | -41.63M | -84.54M | -67.17M | -15.99M | -40.08M | 13.83M | -16.47M | -10.49M | -16.05M |
Income tax expense | 14K | 28K | -196K | -2.79M | 280K | -33.91K | 1.96M | 364.14K | -543.50K | -1.05M |
Net income | -31.54M | -41.65M | -84.34M | -64.38M | -16.27M | -40.05M | 11.86M | -16.47M | -10.49M | -16.05M |
Earnings per share | ||||||||||
Basic EPS | -113.58 | -1.06K | -2.33K | -2.52K | -819.74 | -3.31K | 1.20K | -5.38K | -13.57K | 0 |
Diluted EPS | -113.58 | -1.06K | -2.33K | -2.52K | -819.74 | -3.31K | 1.20K | -5.38K | -13.57K | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |